DAFTAR PUSTAKA

American Cancer Society. 2012. Second Cancers Caused by Treatment.

American Cancer Society. 2008. Global Cance Facts and Figures 2nd Edition.
Bawadi, H.A., Bansode, R.R., Trappey, A., Truax, R.E., Losso, J.N. (2005).
Inhibition of caco 2 colon, MCF- and Hs5787 breast, and DU 145
prostatic cancer cell proliferation by water soluble black bean condensed
tannins. Elsevier, 218, pp. 153-161.
Benedet JL, Bender H, Jones H, Ngan HYS, Pecorelli S. 2000. Staging
classifications and clinical practice guidelines of gynaecologic cancers.
International Journal of Gynecology and Obstetrics. September;70:41-9.
Blecher, C., Graves, KC., Desautin, C., Edward, B., Ferlay, J., Forman, D., et al.
(2008). Global Cancer Fact and Figures. American Cancer Society. Ed 2.
Atalanta.
CDC. 2010. Cervical Cancer. Available from: www.cdc.gov/cancer/knowledge.
American Cancer Society. Cervical Cancer
Cheng MCE. 1990. Role Of Surgery in The Treatment of Cancer of The Cervix.
Singapore Med J. ; 31:253-4.
De Boer MA, Peters LA, Aziz MF, Siregar B, Cornain S, Vrede MA, Jordanova
ES, et al. 2005. Human papillomavirus type 18 variants: Histopathology
and E6/E7 polymorphism in three countries. Int J Cancer. ;114:422-5.
Devi Pu. Basics of Carcinogenesis. Health Administrator. 57(1):16-21.
Dorland. 2012. Dorlands illustrated medical dictionary 32nd Ed. English.
Elsevier.
Fda.gov. United States: FDA approves first drug treatment for late-stage cervical
cancer.

[cited

2012

Feb

25].

Available

from:

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/
ucm108672.htm
Ferreira CG, Epping M, Kruyt FAE. 2002. Apoptosis: Target of Cancer Therapy.
American Association for Cancer Research. ;8:2024-2030.

Fitriasari A, Susidarti RA, Meiyanto E. 2010. Peningkatan Efek Sitotoksik

Doxorubicin oleh Naringenin melalui Pemacuan Apoptosis Sel Kanker
Payudara MCF-7. Jurnal Bahan Alam Indonesia ISSN. ; 7:165-70.
Fotiou SK. 2001. Carcinoma of the Uterine Cervix -- Prognostic Implications of
the Mode of Therapy and Quality of Life. CME Journal of Gynecology
Oncology. ; 6:385-90.
Fuertes MA, Castilla J, Alonso C, Prez JM. (2003). Cisplatin biochemical
mechanism of action: from cytotoxicity to induction of cell death
through interconnections between apoptotic and necrotic pathways.
Departamento de Qumica Inorgnica, Facultad de Ciencias, Universidad
Autnoma de Madrid, Cantoblanco, 28049-Madrid, Spain. Curr Med
Chem. :3:257-66.
Gewies A. Introduction to apoptosis. [Online]. [cited 2012 Feb 25]. Available
from: http://www.ihcworld.com/_books/apointro.pdf.
GLOBOCAN. 2008. International Agency for Research on Cancer .; Available
from: http://globocan.iarc.fr/factsheet.asp
Gomez DT, Santos JL. 2007. Human Papillomavirus Infection And Cervical
Cancer: Pathogenesis And Epidemiology. Dalam: A. Mendez-Vilas,
(Ed.). Communicating Current Research and Educational Topics and
Trends in Applied Microbiology. Formatex research center;
Grace VMB. 2009. HPV type 18 is more oncopotent than HPV16 in uterine
cervical carcinogenesis although HPV16 is the prevalent type in
Chennai, India. Indian Journal of Cancer. Jun 25;46(3):203-7.
Gynaecancercentre.gov.au. Australia: National Center for Gynaecological Cancer.
[cited

2012

Feb

20].

Available

from

http://www.canceraustralia.gov.au/sites/default/files/publications/Treatm
ent_options_cervical_cancer%5B1%5D.pdf.
Hanahan D, Weinberg RA. 2000. The Hallmarks of Cancer. Cell. ; 100:57-70.
Haverkos HW. 2005. Mutifactorial Etiology of Cervical Cancer: A Hypothesis.
Medscape. Nov 11;7(4):56
Health NIo. 2008. What You Need To Know About Cervical Cancer.

Jemal, A., Bray, F., Ferlay, J., Melissa, M., & Formal, D. (2011, April). Global
Cancer Statistic. American Cancer Society, 61 (2), pp. 69-80.
Kumar V, Abbas AK, Fausto N, Mitchell R. 2012. Robbins Basic Pathology. 8th
ed. United States. Elsevier;
Kanadoswami, C., Lee, L.T., Lee, P.P.H., Hwang, J.J., Ke, F.C., Huary, Y.I., dkk.
(2005). The antitumor activities of flavonoids. Institute of Biological
Chemistry, 9, pp. 895-904.
Menteri Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik
Indonesia Nomor 796/MENKES/SK/VII/2010. Tentang Penanggulangan
Kanker Payudara dan Kanker Leher Rahim.
Motoyama S, Llave CAL, Villanueva SL, Maruo T. 2004. The Role of Human
Papilloma Virus in the Molecular Biology of Cervical Carcinogenesis.
Kobe J

Med Sci. ;50(1):9-15.

M. H.N.Tattersall. 2006. Chemotherapy in cervical cancer: Is cisplatin alone still

the standard of care?. Annuls of Oncology 12: 883. 2001. Department of Cancer
Medicine. University of Sydney. NSW, Australia
Myrna Candelaria1, Alicia Garcia-Arias1, Lucely Cetina1 and Alfonso DueasGonzalez2*
Ni, LH., Patel, F., Chakraborty, S., & Sharma, S. (2005). The Oncologic
Management of Carcinoma Cervix after Primary Treament Failure
Indian J Palliat Case, 11, pp. 82-92.
Prayitno A, Darmawan R, Yuliadi I, Mudigdo A. 2005. Ekspresi Protein p53, Rb
dan

c-myc

pada

Kanker

Serviks

Uteri

dengan

Pengecetan

Immunohistokimia. Biodiversitas. Juli;6(3):157-159.

Rasjidi I. 2009. Epidemiologi Kanker Serviks. Indonesian Journal of
Cancer.;III:103-8.
Saizarbibria, TC., Montila, L., Rodniquez, M., Castillo, A., & Hasegawa, M.
(2009, December). Xymarginatin: a new acebgenin inhibitor of
mitochondrial electron transport from xylopia emargination Mard.
Revista brasileira de farmacognisia, pp. 19.
Setiawati A, Septisetyani EP, Wijayanti TR, Rokhman MR. Sambung Nyawa
(Gynura procumbens (Lour.) Merr.) Sebagai Agen Kemopreventif.
Cancer Chemoprevention Research Center.

Stephend, LJ. & Brysan, P. (2008). Human Papilloma Virus-lesa from history and
Challenge for the Future. JOGC, pp. 1025-1033.
Taylor, L. (2002). Technical Data Report for Graviola Annona Muricata.
Tommasino M, Accardi R, Caldeira S, Dong W, Malanchi I, Smet A, et al. 2003.
The Role of TP53 in Cervical Carcinogenesis. International Agency for
Research on Cancer. ;21:307-9.
Uses, E. & Islands, C. (2004). Graviola-Annon Muricata In Vitro, pp. 1-10.
Vermorken JB, Eisenhauer EA. Current developments in the treatment of cervical
cancer. CME Journal of Gynaecologic Oncology. 52-7.
WHO/ICO Information Celta on HPV and Cervical Cancer. (2010). (HPV
information Centre). Human Papillomavirus and Related Cancers.
Available from: <www.who.int/hpvcentre> [Accessed tgl bulan tahun].
Yan Hu, Zhi-Qiang Cai, Xiao-Yan Su. Concurrent Weekly Cisplatin Versus
Triweekly Cisplatin with Radiotherapy in the Treatment of Cervical
Cancer: A Meta-analysis Result. Asian Pacific J Cancer Prev, 13 (9),
4301-4304

weekly Cisplatin with Radiotherapy for Cervical Cancer: A Meta- analysis. Availablefrom:
<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

(Accessed 19/04/13)

Weekly Versus Triweekly Cisplan with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

Availablefrom:
(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

Availablefrom:
(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

Availablefrom:
(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

Availablefrom:
(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

Availablefrom:

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

Availablefrom:

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

Availablefrom:

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

Availablefrom:

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

Availablefrom:

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

Availablefrom:

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

Availablefrom:

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

Availablefrom:

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

(Accessed 19/04/13)-

analysis. Availablefrom: <DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

(Accessed 19/04/13) Weekly Versus Triweekly Cisplatin with Radiotherapy for
Cervical

Cancer:

Meta-

analysis.

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

Availablefrom:
(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

Availablefrom:
(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

Availablefrom:
(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

Availablefrom:
(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

Availablefrom:
(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301>

Availablefrom:
(Accessed 19/04/13)

Weekly Versus Triweekly Cisplatin with Radiotherapy for Cervical Cancer: A

Meta-

analysis.

Availablefrom:

<DOI:http://dx.doi.org/10.7314/APJCP.2012.13.9.4301> (Accessed 19/04/13)